Sandbox g50: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
mNo edit summary
Line 1: Line 1:


[[#Neisseria gonorrhoeae, treatment|Neisseria gonorrhoeae, treatment]]
[[#Neisseria gonorrhoeae, treatment|Neisseria gonorrhoeae, treatment]]


<div id="Neisseria gonorrhoeae, treatment">123</div>
<div id="Neisseria gonorrhoeae, treatment">123</div>


<h3>Bacteria – Gram-Positive Cocci</h3>


* '''Neisseria gonorrhoeae, treatment'''<ref>{{Cite journal| issn = 1545-8601| volume = 64| issue = RR-03| pages = 1–137| last1 = Workowski| first1 = Kimberly A.| last2 = Bolan| first2 = Gail A.| title = Sexually transmitted diseases treatment guidelines, 2015| journal = MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control| date = 2015-06-05| pmid = 26042815}}</ref>
[[Enterococcus faecalis]] &nbsp;●&nbsp;
 
[[Enterococcus faecium]] &nbsp;●&nbsp;
:* '''1. Gonococcal infections in adolescents and adults'''
[[Staphylococcus aureus]] &nbsp;●&nbsp;
::* '''1.1 Uncomplicated gonococcal infections of the cervix, urethra, and rectum'''
[[CoNS|Staphylococcus, coagulase-negative species]] &nbsp;●&nbsp;
:::* Preferred regimen: [[Ceftriaxone]] 250 mg IM in a single dose {{and}} [[Azithromycin]] 1 g PO in a single dose
[[Staphylococcus epidermidis]] &nbsp;●&nbsp;
:::* Alternative regimen: [[Cefixime]] 400 mg PO in a single dose {{and}} [[Azithromycin]] 1 g PO in a single dose (if ceftriaxone is not available)
[[Staphylococcus haemolyticus]] &nbsp;●&nbsp;
 
[[Staphylococcus lugdunensis]] &nbsp;●&nbsp;
::*'''1.2 Uncomplicated gonococcal infections of the pharynx'''
[[Staphylococcus saprophyticus]] &nbsp;●&nbsp;
:::* Preferred regimen: [[Ceftriaxone]] 250 mg IM in a single dose {{and}} [[Azithromycin]] 1 g PO in a single dose
[[Streptobacillus moniliformis]] &nbsp;●&nbsp;
[[Streptococcus anginosus]] &nbsp;●&nbsp;
[[Streptococcus pneumoniae]] &nbsp;●&nbsp;
[[Streptococcus pyogenes]] &nbsp;●&nbsp;
[[Streptococcus agalactiae]] &nbsp;●&nbsp;


::::* '''1.2.1 Management of sex partners'''
<h3>Bacteria – Gram-Positive Bacilli</h3>
:::::* Expedited partner therapy: [[Cefixime]] 400 mg PO in a single dose {{and}} [[Azithromycin]] 1 g PO in a single dose
[[Actinomyces israelii]] &nbsp;●&nbsp;
:::::* Recent sex partners (i.e., persons having sexual contact with the infected patient within the 60 days preceding onset of symptoms or gonorrhea diagnosis) should be referred for evaluation, testing, and presumptive dual treatment.
[[Arcanobacterium haemolyticum]] &nbsp;●&nbsp;
:::::* If the patient’s last potential sexual exposure was >60 days before onset of symptoms or diagnosis, the most recent sex partner should be treated.
[[Bacillus anthracis]] &nbsp;●&nbsp;
:::::* To avoid reinfection, sex partners should be instructed to abstain from unprotected sexual intercourse for 7 days after they and their sexual partner(s) have completed treatment and after resolution of symptoms, if present.
[[Bacillus cereus]] &nbsp;●&nbsp;
[[Bacillus subtilis]] &nbsp;●&nbsp;
[[Clostridium difficile]] &nbsp;●&nbsp;
[[Clostridium perfringens]] &nbsp;●&nbsp;
[[Clostridium tetani]] &nbsp;●&nbsp;
[[Corynebacterium diphtheriae]] &nbsp;●&nbsp;
[[Corynebacterium jeikeium]] &nbsp;●&nbsp;
[[Corynebacterium urealyticum]] &nbsp;●&nbsp;
[[Coxiella burnetii]] &nbsp;●&nbsp;
[[Ehrlichia]] &nbsp;●&nbsp;
[[Erysipelothrix rhusiopathiae]] &nbsp;●&nbsp;
[[Listeria monocytogenes]] &nbsp;●&nbsp;
[[Lactobacillus]] &nbsp;●&nbsp;
[[Leuconostoc]] &nbsp;●&nbsp;
[[Nocardia]] &nbsp;●&nbsp;
[[Propionibacterium acnes]] &nbsp;●&nbsp;
[[Rhodococcus equi]] &nbsp;●&nbsp;
[[Rickettsia]] &nbsp;●&nbsp;


::::* '''1.2.2 Allergy, intolerance, and adverse reactions'''
<h3>Bacteria – Gram-Negative Cocci and Coccobacilli</h3>
:::::* Preferred regimen (1): [[Gemifloxacin]] 320 mg PO in a single dose {{and}} [[Azithromycin]] 2 g PO in a single dose
<li>[[Aggregatibacter aphrophilus]] &nbsp;●&nbsp;
:::::* Preferred regimen (2): [[Gentamicin]] 240 mg IM in a single dose {{and}} [[Azithromycin]] 2 g PO in a single dose
<li>[[Bordetella pertussis]] &nbsp;●&nbsp;
:::::: Note: Use of ceftriaxone or cefixime is contraindicated in persons with a history of an IgE-mediated penicillin allergy (e.g., anaphylaxis, Stevens Johnson syndrome, and toxic epidermal necrolysis).
<li>[[Brucella]] &nbsp;●&nbsp;
<li>[[Eikenella corrodens]] &nbsp;●&nbsp;
<li>[[Haemophilus ducreyi]] &nbsp;●&nbsp;
<li>[[Haemophilus influenzae]] &nbsp;●&nbsp;
<li>[[Neisseria gonorrhoeae]] &nbsp;●&nbsp;
<li>[[Neisseria meningitidis]] &nbsp;●&nbsp;
<li>[[Moraxella catarrhalis]] &nbsp;●&nbsp;
<li>[[Pasteurella multocida]] &nbsp;●&nbsp;


::::* '''1.2.3 Pregnancy'''
<h3>Bacteria – Spirochetes</h3>
:::::* Preferred regimen: [[Ceftriaxone]] 250 mg IM in a single dose {{and}} [[Azithromycin]] 1 g PO in a single dose
<li>[[Borrelia burgdorferi]] &nbsp;●&nbsp;


::::* '''1.2.4 Suspected cephalosporin treatment failure'''
<li>[[Borrelia recurrentis]] &nbsp;●&nbsp;
:::::* Preferred regimen: [[Ceftriaxone]] 250 mg IM in a single dose {{and}} [[Azithromycin]] 1 g PO in a single dose
<li>[[Leptospira]] &nbsp;●&nbsp;
:::::* Alternative regimen (1): [[Gemifloxacin]] 320 mg PO  single dose  {{and}} [[Azithromycin]] 2 g PO  single dose (when isolates have elevated cephalosporin MICs)
<li>[[Treponema pallidum]] &nbsp;●&nbsp;
:::::* Alternative regimen (2): [[Gentamicin]] 240 mg IM  single dose {{and}} [[Azithromycin]] 2 g PO single dose (when isolates have elevated cephalosporin MICs)
:::::* Alternative regimen (3): [[Ceftriaxone]] 250 mg IM as a single dose {{and}} [[Azithromycin]] 2 g PO as a single dose (failure after treatment with cefixime and azithromycin)
:::::: Note: Treatment failure should be considered in: (1) persons whose symptoms do not resolve within 3–5 days after appropriate treatment and report no sexual contact during the post-treatment follow-up period; (2) persons with a positive test-of-cure (i.e., positive culture ≥ 72 hours or positive NAAT ≥ 7 days after receiving recommended treatment) when no sexual contact is reported during the post-treatment follow-up period; (3) persons who have a positive culture on test-of-cure (if obtained) if there is evidence of decreased susceptibility to cephalosporins on antimicrobial susceptibility testing, regardless of whether sexual contact is reported during the post-treatment follow-up period.


::* '''1.3 Gonococcal conjunctivitis'''
<h3>Bacteria – Gram-Negative Bacilli</h3>
:::* Preferred regimen: [[Ceftriaxone]] 250 mg IM in a single dose {{and}} [[Azithromycin]] 1 g PO in a single dose
:::: Note: Consider one-time lavage of the infected eye with saline solution.


::::* '''1.3.1 Management of sex partners'''
[[Aeromonas hydrophila]] &nbsp;●&nbsp;
:::::* Patients should be instructed to refer their sex partners for evaluation and treatment.
[[Citrobacter koseri]] &nbsp;●&nbsp;
[[Citrobacter freundii]] &nbsp;●&nbsp;
[[Enterobacter cloacae]] &nbsp;●&nbsp;
[[Enterobacter aerogenes]] &nbsp;●&nbsp;
[[Escherichia coli]] &nbsp;●&nbsp;
[[Klebsiella pneumoniae]] &nbsp;●&nbsp;
[[Klebsiella rhinoscleromatis]] &nbsp;●&nbsp;
[[Morganella morganii]] &nbsp;●&nbsp;
[[Proteus vulgaris]] &nbsp;●&nbsp;
[[Providencia]] &nbsp;●&nbsp;
[[Salmonella]] &nbsp;●&nbsp;
[[Serratia marcescens]] &nbsp;●&nbsp;
[[Shigella]] &nbsp;●&nbsp;
[[Acinetobacter baumannii]] &nbsp;●&nbsp;
[[Achromobacter xylosoxidans]] &nbsp;●&nbsp;
[[Burkholderia cepacia]] &nbsp;●&nbsp;
[[Burkholderia pseudomallei]] &nbsp;●&nbsp;
[[Stenotrophomonas maltophilia]] &nbsp;●&nbsp;
[[Elizabethkingia meningoseptica]] &nbsp;●&nbsp;
[[Moraxella catarrhalis]] &nbsp;●&nbsp;
<li>[[Bartonella bacilliformis]] &nbsp;●&nbsp;
<li>[[Bartonella henselae]] &nbsp;●&nbsp;
<li>[[Bartonella quintana]] &nbsp;●&nbsp;
[[Campylobacter fetus]] &nbsp;●&nbsp;
[[Campylobacter jejuni]] &nbsp;●&nbsp;
<li>[[Capnocytophaga]] &nbsp;●&nbsp;
<li>[[Francisella tularensis]] &nbsp;●&nbsp;
<li>[[Helicobacter pylori]] &nbsp;●&nbsp;
<li>[[Legionella pneumophila]] &nbsp;●&nbsp;
<li>[[Plesiomonas shigelloides]] &nbsp;●&nbsp;
<li>[[Pseudomonas aeruginosa]] &nbsp;●&nbsp;


::* '''1.4 Disseminated gonococcal infection''' 
[[Vibrio cholerae]] &nbsp;●&nbsp;
::::* '''1.4.1 Arthritis and arthritis-dermatitis syndrome '''
[[Vibrio parahaemolyticus]] &nbsp;●&nbsp;
:::::* Preferred regimen: [[Ceftriaxone]] 1 g IM/IV q24h for 7 days {{and}} [[Azithromycin]] 1 g PO in a single dose
[[Vibrio vulnificus]] &nbsp;●&nbsp;
:::::* Alternative regimen: [[Cefotaxime]] 1 g IV q8h for 7 days {{or}} [[Ceftizoxime]] 1 g IV q 8 h  for 7 days {{and}} [[Azithromycin]] 1 g PO in a single dose


::::* '''1.4.2 Gonococcal meningitis and endocarditis'''
<h3>Bacteria – Miscellaneous</h3>
:::::* Preferred regimen : [[Ceftriaxone]] 1-2 g IV  q 12-24 h  for 10-14 days {{and}} [[Azithromycin]] 1 g PO in a single dose
<li>[[Gardnerella vaginalis]] &nbsp;●&nbsp;
<li>[[Stenotrophomonas maltophilia]] &nbsp;●&nbsp;
<li>[[Acinetobacter baumannii]] &nbsp;●&nbsp;
<li>[[Chlamydia pneumoniae]] &nbsp;●&nbsp;
<li>[[Chlamydia psittaci]] &nbsp;●&nbsp;
<li>[[Coxiella burnetii]] &nbsp;●&nbsp;
<li>[[Mycoplasma pneumoniae]] &nbsp;●&nbsp;


:* '''2. Gonococcal infections among neonates'''
<h3>Bacteria – Anaerobic Gram-Negative Bacilli</h3>
::* '''2.1 Ophthalmia neonatorum caused by N. gonorrhoeae'''
<li>[[Bacteroides fragilis]] &nbsp;●&nbsp;
:::* Preferred regimen: [[Ceftriaxone]] 25-50 mg/kg IV or IM in a single dose, not to exceed 125 mg
<li>[[Fusobacterium necrophorum]] &nbsp;●&nbsp;


::::* '''2.1.1 Management of mothers and their sex partners'''
<h3>Fungi</h3>
:::::* Mothers of infants with ophthalmia neonatorum caused by N. gonorrhoeae should be evaluated, tested, and presumptively treated for gonorrhea, along with their sex partner(s).
<li>[[Aspergillosis]] &nbsp;●&nbsp;
<li>[[Blastomycosis]] &nbsp;●&nbsp;
<li>[[Paracoccidioidomycosis]] &nbsp;●&nbsp;
<li>[[Candidiasis]] &nbsp;●&nbsp;
<li>[[Chromoblastomycosis]] &nbsp;●&nbsp;
<li>[[Coccidioidomycosis]] &nbsp;●&nbsp;
<li>[[Cryptococcosis]] &nbsp;●&nbsp;
<li>[[Dermatophytosis]] &nbsp;●&nbsp;
<li>[[Onychomycosis]] &nbsp;●&nbsp;
<li>[[Tinea capitis]] &nbsp;●&nbsp;
<li>[[Tinea corporis]] &nbsp;●&nbsp;
<li>[[Tinea pedis]] &nbsp;●&nbsp;
<li>[[Tinea cruris]] &nbsp;●&nbsp;
<li>[[Tinea versicolor]] &nbsp;●&nbsp;
<li>[[Histoplasmosis]] &nbsp;●&nbsp;
<li>[[Mucormycosis]] &nbsp;●&nbsp;
<li>[[Penicilliosis]] &nbsp;●&nbsp;
<li>[[Sporotrichosis]] &nbsp;●&nbsp;
<li>[[Pneumocystis jiroveci]] &nbsp;●&nbsp;


::* '''2.2 Disseminated gonococcal infection and gonococcal scalp abscesses in neonates'''
<h3>Mycobacteria</h3>
:::* Preferred regimen: [[Ceftriaxone]] 25-50 mg/kg/day  IM/IV qd for 7 days {{or}} [[Cefotaxime]] 25 mg/kg IV /IM  q12h for 7 days.
<li>[[Mycobacterium tuberculosis]] &nbsp;●&nbsp;
:::: Note (1): The duration of treatment is 10-14 days if meningitis is documented.
<li>[[Mycobacterium abscessus]] &nbsp;●&nbsp;
:::: Note (2): Ceftriaxone should be administered cautiously to hyperbilirubinemic infants, especially those born prematurely.
<li>[[Mycobacterium bovis]] &nbsp;●&nbsp;
<li>[[Mycobacterium avium-intracellulare]] &nbsp;●&nbsp;
<li>[[Mycobacterium celatum]] &nbsp;●&nbsp;
<li>[[Mycobacterium chelonae]] &nbsp;●&nbsp;
<li>[[Mycobacterium foruitum]] &nbsp;●&nbsp;
<li>[[Mycobacterium haemophilum]] &nbsp;●&nbsp;
<li>[[Mycobacterium genavense]] &nbsp;●&nbsp;
<li>[[Mycobacterium gordonae]] &nbsp;●&nbsp;
<li>[[Mycobacterium kansasii]] &nbsp;●&nbsp;
<li>[[Mycobacterium marinum]] &nbsp;●&nbsp;
<li>[[Mycobacterium scrofulaceum]] &nbsp;●&nbsp;
<li>[[Mycobacterium simiae]] &nbsp;●&nbsp;
<li>[[Mycobacterium ulcerans]] &nbsp;●&nbsp;
<li>[[Mycobacterium xenopi]] &nbsp;●&nbsp;
<li>[[Mycobacterium leprae]] &nbsp;●&nbsp;


::::* '''2.2.1 Management of mothers and their sex partners'''
<h3>Parasites – Intestinal Protozoa</h3>
:::::* Mothers of infants who have DGI or scalp abscesses caused by N. gonorrhoeae should be evaluated, tested, and presumptively treated for gonorrhea, along with their sex partner(s).
<li>[[Balantidium coli]] &nbsp;●&nbsp;
<li>[[Blastocystis hominis]] &nbsp;●&nbsp;
<li>[[Cryptosporidium parvum]] &nbsp;●&nbsp;
<li>[[Cryptosporidium hominis]] &nbsp;●&nbsp;
<li>[[Cyclospora cayetanensis]] &nbsp;●&nbsp;
<li>[[Dientamoeba fragilis]] &nbsp;●&nbsp;
<li>[[Entamoeba histolytica]] &nbsp;●&nbsp;
<li>[[Giardia lamblia]] &nbsp;●&nbsp;
<li>[[Isospora belli]] &nbsp;●&nbsp;
<li>[[Microsporidiosis]] &nbsp;●&nbsp;


::* '''2.3 Neonates born to mothers who have gonococcal infection'''
<h3>Parasites – Extraintestinal Protozoa</h3>
:::* Preferred regimen: [[Ceftriaxone]] 25-50 mg/kg IM/IV in a single dose, not to exceed 125 mg
<li>[[Primary amoebic meningoencephalitis]] &nbsp;●&nbsp;
<li>[[Acanthamoeba]] &nbsp;●&nbsp;
<li>[[Balamuthia mandrillaris]] &nbsp;●&nbsp;
<li>[[Naegleria fowleri]] &nbsp;●&nbsp;
<li>[[Babesia microti]] &nbsp;●&nbsp;
<li>[[Leishmaniasis]] &nbsp;●&nbsp;
<li>[[Plasmodium]] &nbsp;●&nbsp;
<li>[[Toxoplasma gondii]] &nbsp;●&nbsp;
<li>[[Trichomonas vaginalis]] &nbsp;●&nbsp;
<li>[[African trypanosomiasis]] &nbsp;●&nbsp;
<li>[[American trypanosomiasis]] &nbsp;●&nbsp;


::::* '''2.3.1 Management of mothers and their sex partners'''
<h3>Parasites – Intestinal Nematodes (Roundworms)</h3>
:::::* Mothers who have gonorrhea and their sex partners should be evaluated, tested, and presumptively treated for gonorrhea.
<li>[[Ascaris lumbricoides]] &nbsp;●&nbsp;
<li>[[Capillaria philippinensis]] &nbsp;●&nbsp;
<li>[[Enterobius vermicularis]] &nbsp;●&nbsp;
<li>[[Necator americanus]] &nbsp;●&nbsp;
<li>[[Ancylostoma duodenale]] &nbsp;●&nbsp;
<li>[[Strongyloides stercoralis]] &nbsp;●&nbsp;
<li>[[Trichuris trichiura]] &nbsp;●&nbsp;


:* '''3. Gonococcal infections among infants and children'''
<h3>Parasites – Extraintestinal Nematodes (Roundworms)</h3>
::* '''3.1 Infants and children who weigh ≤ 45 kg and who have uncomplicated gonococcal vulvovaginitis, cervicitis, urethritis, pharyngitis, or proctitis'''
<li>[[Ancylostoma braziliense]] &nbsp;●&nbsp;
:::* Preferred regimen: [[Ceftriaxone]] 25-50 mg/kg IM/IV in a single dose, not to exceed 125 mg
<li>[[Angiostrongylus cantonensis]] &nbsp;●&nbsp;
<li>[[Filariasis]] &nbsp;●&nbsp;
<li>[[Onchocerciasis]] &nbsp;●&nbsp;
<li>[[Wuchereria bancrofti]] &nbsp;●&nbsp;
<li>[[Brugia malayi]] &nbsp;●&nbsp;
<li>[[Gnathostoma spinigerum]] &nbsp;●&nbsp;
<li>[[Toxocariasis]] &nbsp;●&nbsp;
<li>[[Trichinella spiralis]] &nbsp;●&nbsp;


::* '''3.2 Children who weigh > 45 kg and who have uncomplicated gonococcal vulvovaginitis, cervicitis, urethritis, pharyngitis, or proctitis'''
<h3>Parasites – Trematodes (Flukes)</h3>
:::* Preferred regimen: [[Ceftriaxone]] 250 mg IM in a single dose {{and}} [[Azithromycin]] 1g PO in a single dose
<li>[[Clonorchis sinensis]] &nbsp;●&nbsp;
:::* Alternative regimen: [[Cefixime]] 400 mg PO  single dose {{and}} [[Azithromycin]] 1 g PO single dose.(If ceftriaxone is not available) 
<li>[[Dicrocoelium dendriticum]] &nbsp;●&nbsp;
<li>[[Fasciola hepatica]] &nbsp;●&nbsp;
<li>[[Paragonimus westermani]] &nbsp;●&nbsp;
<li>[[Schistosomiasis]] &nbsp;●&nbsp;


::* '''3.3 Children who weigh ≤ 45 kg and who have bacteremia or arthritis'''
<h3>Parasites – Cestodes (Tapeworms)</h3>
:::* Preferred regimen: [[Ceftriaxone]] 50 mg/kg (maximum dose: 1 g) IM/IV q24h for 7 days
<li>[[Echinococcus]] &nbsp;●&nbsp;
<li>[[Neurocysticercosis]] &nbsp;●&nbsp;
<li>[[Sparganosis]] &nbsp;●&nbsp;


::* '''3.4 Children who weigh > 45 kg and who have bacteremia or arthritis'''
<h3>Parasites – Ectoparasites</h3>
:::* Preferred regimen: [[Ceftriaxone]] 1 g IM/IV q24h for 7 days
<li>[[Body lice]] &nbsp;●&nbsp;
<li>[[Head lice]] &nbsp;●&nbsp;
<li>[[Pubic lice]] &nbsp;●&nbsp;
<li>[[Scabies]] &nbsp;●&nbsp;
<li>[[Myiasis]] &nbsp;●&nbsp;


* '''Neisseria gonorrhoeae, prophylaxis'''<ref>{{Cite journal| issn = 1545-8601| volume = 64| issue = RR-03| pages = 1–137| last1 = Workowski| first1 = Kimberly A.| last2 = Bolan| first2 = Gail A.| title = Sexually transmitted diseases treatment guidelines, 2015| journal = MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control| date = 2015-06-05| pmid = 26042815}}</ref>
<h3>Viruses</h3>
<li>[[Adenovirus]] &nbsp;●&nbsp;
<li>[[SARS]] &nbsp;●&nbsp;
<li>[[Cytomegalovirus]] &nbsp;●&nbsp;
<li>[[Enterovirus D68]] &nbsp;●&nbsp;
<li>[[Ebola virus]] &nbsp;●&nbsp;
<li>[[Marburg virus]] &nbsp;●&nbsp;
<li>[[Hantavirus]] &nbsp;●&nbsp;
<li>[[Dengue virus]] &nbsp;●&nbsp;
<li>[[West Nile virus]] &nbsp;●&nbsp;
<li>[[Yellow Fever]] &nbsp;●&nbsp;
<li>[[Chikungunya virus]] &nbsp;●&nbsp;
<li>[[Hepatitis A virus]] &nbsp;●&nbsp;
<li>[[Hepatitis B virus]] &nbsp;●&nbsp;
<li>[[Hepatitis C virus]] &nbsp;●&nbsp;
<li>[[Hepatitis D virus]] &nbsp;●&nbsp;
<li>[[Hepatitis E virus]] &nbsp;●&nbsp;
<li>[[Epstein-Barr virus]] &nbsp;●&nbsp;
<li>[[Human herpesvirus 6]] &nbsp;●&nbsp;
<li>[[Roseola|Human herpesvirus 7]] &nbsp;●&nbsp;
<li>[[Kaposi's sarcoma-associated herpesvirus|Human herpesvirus 8 (KSHV)]] &nbsp;●&nbsp;
<li>[[Herpes simplex virus]] &nbsp;●&nbsp;
<li>[[Varicella-zoster virus]] &nbsp;●&nbsp;
<li>[[Human papillomavirus]] &nbsp;●&nbsp;
<li>[[Influenza A]] &nbsp;●&nbsp;
<li>[[Influenza B]] &nbsp;●&nbsp;
<li>[[Avian influenza]] &nbsp;●&nbsp;
<li>[[Swine influenza]] &nbsp;●&nbsp;
<li>[[Measles]] &nbsp;●&nbsp;
<li>[[Middle East respiratory syndrome]] &nbsp;●&nbsp;
<li>[[Paramyxovirus]] &nbsp;●&nbsp;
<li>[[Parvovirus B19]] &nbsp;●&nbsp;
<li>[[BK virus]] &nbsp;●&nbsp;
<li>[[JC virus]] &nbsp;●&nbsp;
<li>[[Rabies]] &nbsp;●&nbsp;
<li>[[Respiratory Syncytial Virus]] &nbsp;●&nbsp;
<li>[[Rhinovirus]] &nbsp;●&nbsp;
<li>[[Rotavirus]] &nbsp;●&nbsp;
<li>[[Smallpox]] &nbsp;●&nbsp;
<li>[[HIV/AIDS]] &nbsp;●&nbsp;


:* '''1. Ophthalmia neonatorum'''
<div style="font-size: 8px;">[[Infectious Disease Project Pathogen-Based Infections#WikiDoc Infectious Disease Project — Pathogen-Based Infections|<code>Return to Top</code>]]</div>
::* Preferred regimen: [[Erythromycin]] 0.5% ophthalmic ointment in each eye in a single application at birth
::* Alternative regimen: [[Ceftriaxone]] 25–50 mg/kg IV/IM in a single dose, not to exceed 125 mg (if erythromycin ointment is not available)

Revision as of 17:43, 29 June 2015


Neisseria gonorrhoeae, treatment

123

Bacteria – Gram-Positive Cocci

Enterococcus faecalis  ●  Enterococcus faecium  ●  Staphylococcus aureus  ●  Staphylococcus, coagulase-negative species  ●  Staphylococcus epidermidis  ●  Staphylococcus haemolyticus  ●  Staphylococcus lugdunensis  ●  Staphylococcus saprophyticus  ●  Streptobacillus moniliformis  ●  Streptococcus anginosus  ●  Streptococcus pneumoniae  ●  Streptococcus pyogenes  ●  Streptococcus agalactiae  ● 

Bacteria – Gram-Positive Bacilli

Actinomyces israelii  ●  Arcanobacterium haemolyticum  ●  Bacillus anthracis  ●  Bacillus cereus  ●  Bacillus subtilis  ●  Clostridium difficile  ●  Clostridium perfringens  ●  Clostridium tetani  ●  Corynebacterium diphtheriae  ●  Corynebacterium jeikeium  ●  Corynebacterium urealyticum  ●  Coxiella burnetii  ●  Ehrlichia  ●  Erysipelothrix rhusiopathiae  ●  Listeria monocytogenes  ●  Lactobacillus  ●  Leuconostoc  ●  Nocardia  ●  Propionibacterium acnes  ●  Rhodococcus equi  ●  Rickettsia  ● 

Bacteria – Gram-Negative Cocci and Coccobacilli

  • Aggregatibacter aphrophilus  ● 
  • Bordetella pertussis  ● 
  • Brucella  ● 
  • Eikenella corrodens  ● 
  • Haemophilus ducreyi  ● 
  • Haemophilus influenzae  ● 
  • Neisseria gonorrhoeae  ● 
  • Neisseria meningitidis  ● 
  • Moraxella catarrhalis  ● 
  • Pasteurella multocida  ● 

    Bacteria – Spirochetes

  • Borrelia burgdorferi  ● 
  • Borrelia recurrentis  ● 
  • Leptospira  ● 
  • Treponema pallidum  ● 

    Bacteria – Gram-Negative Bacilli

    Aeromonas hydrophila  ●  Citrobacter koseri  ●  Citrobacter freundii  ●  Enterobacter cloacae  ●  Enterobacter aerogenes  ●  Escherichia coli  ●  Klebsiella pneumoniae  ●  Klebsiella rhinoscleromatis  ●  Morganella morganii  ●  Proteus vulgaris  ●  Providencia  ●  Salmonella  ●  Serratia marcescens  ●  Shigella  ●  Acinetobacter baumannii  ●  Achromobacter xylosoxidans  ●  Burkholderia cepacia  ●  Burkholderia pseudomallei  ●  Stenotrophomonas maltophilia  ●  Elizabethkingia meningoseptica  ●  Moraxella catarrhalis  ● 

  • Bartonella bacilliformis  ● 
  • Bartonella henselae  ● 
  • Bartonella quintana  ●  Campylobacter fetus  ●  Campylobacter jejuni  ● 
  • Capnocytophaga  ● 
  • Francisella tularensis  ● 
  • Helicobacter pylori  ● 
  • Legionella pneumophila  ● 
  • Plesiomonas shigelloides  ● 
  • Pseudomonas aeruginosa  ●  Vibrio cholerae  ●  Vibrio parahaemolyticus  ●  Vibrio vulnificus  ● 

    Bacteria – Miscellaneous

  • Gardnerella vaginalis  ● 
  • Stenotrophomonas maltophilia  ● 
  • Acinetobacter baumannii  ● 
  • Chlamydia pneumoniae  ● 
  • Chlamydia psittaci  ● 
  • Coxiella burnetii  ● 
  • Mycoplasma pneumoniae  ● 

    Bacteria – Anaerobic Gram-Negative Bacilli

  • Bacteroides fragilis  ● 
  • Fusobacterium necrophorum  ● 

    Fungi

  • Aspergillosis  ● 
  • Blastomycosis  ● 
  • Paracoccidioidomycosis  ● 
  • Candidiasis  ● 
  • Chromoblastomycosis  ● 
  • Coccidioidomycosis  ● 
  • Cryptococcosis  ● 
  • Dermatophytosis  ● 
  • Onychomycosis  ● 
  • Tinea capitis  ● 
  • Tinea corporis  ● 
  • Tinea pedis  ● 
  • Tinea cruris  ● 
  • Tinea versicolor  ● 
  • Histoplasmosis  ● 
  • Mucormycosis  ● 
  • Penicilliosis  ● 
  • Sporotrichosis  ● 
  • Pneumocystis jiroveci  ● 

    Mycobacteria

  • Mycobacterium tuberculosis  ● 
  • Mycobacterium abscessus  ● 
  • Mycobacterium bovis  ● 
  • Mycobacterium avium-intracellulare  ● 
  • Mycobacterium celatum  ● 
  • Mycobacterium chelonae  ● 
  • Mycobacterium foruitum  ● 
  • Mycobacterium haemophilum  ● 
  • Mycobacterium genavense  ● 
  • Mycobacterium gordonae  ● 
  • Mycobacterium kansasii  ● 
  • Mycobacterium marinum  ● 
  • Mycobacterium scrofulaceum  ● 
  • Mycobacterium simiae  ● 
  • Mycobacterium ulcerans  ● 
  • Mycobacterium xenopi  ● 
  • Mycobacterium leprae  ● 

    Parasites – Intestinal Protozoa

  • Balantidium coli  ● 
  • Blastocystis hominis  ● 
  • Cryptosporidium parvum  ● 
  • Cryptosporidium hominis  ● 
  • Cyclospora cayetanensis  ● 
  • Dientamoeba fragilis  ● 
  • Entamoeba histolytica  ● 
  • Giardia lamblia  ● 
  • Isospora belli  ● 
  • Microsporidiosis  ● 

    Parasites – Extraintestinal Protozoa

  • Primary amoebic meningoencephalitis  ● 
  • Acanthamoeba  ● 
  • Balamuthia mandrillaris  ● 
  • Naegleria fowleri  ● 
  • Babesia microti  ● 
  • Leishmaniasis  ● 
  • Plasmodium  ● 
  • Toxoplasma gondii  ● 
  • Trichomonas vaginalis  ● 
  • African trypanosomiasis  ● 
  • American trypanosomiasis  ● 

    Parasites – Intestinal Nematodes (Roundworms)

  • Ascaris lumbricoides  ● 
  • Capillaria philippinensis  ● 
  • Enterobius vermicularis  ● 
  • Necator americanus  ● 
  • Ancylostoma duodenale  ● 
  • Strongyloides stercoralis  ● 
  • Trichuris trichiura  ● 

    Parasites – Extraintestinal Nematodes (Roundworms)

  • Ancylostoma braziliense  ● 
  • Angiostrongylus cantonensis  ● 
  • Filariasis  ● 
  • Onchocerciasis  ● 
  • Wuchereria bancrofti  ● 
  • Brugia malayi  ● 
  • Gnathostoma spinigerum  ● 
  • Toxocariasis  ● 
  • Trichinella spiralis  ● 

    Parasites – Trematodes (Flukes)

  • Clonorchis sinensis  ● 
  • Dicrocoelium dendriticum  ● 
  • Fasciola hepatica  ● 
  • Paragonimus westermani  ● 
  • Schistosomiasis  ● 

    Parasites – Cestodes (Tapeworms)

  • Echinococcus  ● 
  • Neurocysticercosis  ● 
  • Sparganosis  ● 

    Parasites – Ectoparasites

  • Body lice  ● 
  • Head lice  ● 
  • Pubic lice  ● 
  • Scabies  ● 
  • Myiasis  ● 

    Viruses

  • Adenovirus  ● 
  • SARS  ● 
  • Cytomegalovirus  ● 
  • Enterovirus D68  ● 
  • Ebola virus  ● 
  • Marburg virus  ● 
  • Hantavirus  ● 
  • Dengue virus  ● 
  • West Nile virus  ● 
  • Yellow Fever  ● 
  • Chikungunya virus  ● 
  • Hepatitis A virus  ● 
  • Hepatitis B virus  ● 
  • Hepatitis C virus  ● 
  • Hepatitis D virus  ● 
  • Hepatitis E virus  ● 
  • Epstein-Barr virus  ● 
  • Human herpesvirus 6  ● 
  • Human herpesvirus 7  ● 
  • Human herpesvirus 8 (KSHV)  ● 
  • Herpes simplex virus  ● 
  • Varicella-zoster virus  ● 
  • Human papillomavirus  ● 
  • Influenza A  ● 
  • Influenza B  ● 
  • Avian influenza  ● 
  • Swine influenza  ● 
  • Measles  ● 
  • Middle East respiratory syndrome  ● 
  • Paramyxovirus  ● 
  • Parvovirus B19  ● 
  • BK virus  ● 
  • JC virus  ● 
  • Rabies  ● 
  • Respiratory Syncytial Virus  ● 
  • Rhinovirus  ● 
  • Rotavirus  ● 
  • Smallpox  ● 
  • HIV/AIDS  ● 
    • Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_g50&oldid=1114554"